| PP-34 | EMİNE EYLEM | GENÇ | LANGERHANS CELL HISTIOCYTOSIS IN ADULTS: CLINIC PRESENTATION, TREATMENT OPTIONS AND PROGNOSIS |
| PP-35 | NUR | SOYER | RETROSPECTIVE AND MULTICENTER ANALYSIS OF EFFICACY AND SAFETY OF RUXOLITINIB IN 176 TURKISH PATIENTS WITH MYELOFIBROSIS: UPDATED DATA |
| PP-36 | ÖMER | EKİNCİ | HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS ASSOCIATED WITH ACUTE HEPATITIS A DISEASE |
| PP-37 | MEHMET | BANKİR | CLINICAL AND LABORATORY PARAMETERS OF JAK2V617F MUTATION IN ESSENTIAL THROMBOCYTOSIS PATIENTS |
| PP-38 | ÖMER | EKİNCİ | ACQUIRED VON WILLEBRAND DISEASE IN CHRONIC MYELOPROLIFERATIVE DISORDERS |
| PP-39 | AYSUN | ŞENTÜRK YIKILMAZ | THIOL– DISULPHIDE HOMEOSTASIS IN ESSENTIAL THROMBOCYTEMIA PATIENTS |
| PP-40 | MUFİDE | OKAY | DESCRIPTIVE ANALYSIS OF MYELOPROLIFERATIVE DISEASES AND ITS COMPLICATIONS |
| PP-41 | RAFİYE | CİFTCİLER | HIV INFECTION RELATED HAEMATOLOGIC NEOPLASTIC DISEASES |
| PP-42 | ENİSA | ZARİC | PREGNANCY OUTCOMES IN A CASE OF PROTEIN S DEFICIENCY CARRIERS COUPLE |
| PP-43 | SİNAN | DEMİRCİOĞLU | A RARE CAUSE OF PANCYTOPENIA: TRANSFUSION- ASSOCIATED GRAFT VERSUS HOST DISEASE |
| PP-44 | PINAR | CÖMERT | REFRACTORY THROMBOTIC THROMBOCYTOPENIC PURPURA IN A PATIENT WITH KAPOSI SARCOMA |
| PP-45 | ÖMER | EKİNCİ | DECREASED BONE MINERAL DENSITY AND RELATED PARAMETERS IN SEVERE HEMOPHILIA A PATIENTS: A CASE-CONTROL STUDY |
| PP-46 | PINAR | ÇAKAN | IL-1BETA, IL-6 AND TNF-ALPHA LEVELS IN WOMEN WORKING UNDER LONG-TERM (32-36 H) SHIFTS |
| PP-47 | GHADA | ELGOHARY | VITAMIN D INSUFFICIENCY IN NON HODGKIN LYMPHOMA AND ITS RELATION TO ADVERSE PROGNOSTIC FACTORS: A SINGLE CENTER ANALYSIS |
| PP-48 | ISABELLA | LO | THE SAFETY AND EFFICACY OF THE BIOSIMILAR ANTI-CD20 ANTIBODY, TRUXIMA, IN HEAMATOLOGICAL MALIGNANCY |
| PP-49 | MÜRÜVVET SEDA | AYDIN | CAUSES OF THROMBOSIS IN HODGKIN LYMPHOMA: SINGLE CENTER EXPERIENCE |
| PP-50 | MÜRÜVVET SEDA | AYDIN | BRENTUXIMAB VEDOTIN IN CD30+ LYMPHOMAS: SINGLE CENTER EXPERIENCE |
| PP-51 | EMRAH | KILIÇASLAN | A MYCOSIS FUNGOIDES CASE; TWO MONTH LATER AFTER HODGKIN LYMPHOMA TREATMENT |
| PP-52 | ÖMER | EKİNCİ | CLINICAL AND PATHOLOGICAL CHARACTERISTICS OF NON-HODGKIN LYMPHOMA PATIENTS IN EASTERN OF TURKEY: A SINGLE-CENTER STUDY |
| PP-53 | SENEM | MARAL | A RARE PRESENTATION: LUNG ADENOCARCINOMA FOLLOWING BONE MARROW TRANSPLANTATION FOR MANTLE CELL LYMPHOMA |
| PP-54 | AYŞE | UYSAL | AN ATYPICAL PRESENTATION:FOLLICULAR LYMPHOMA WITH PERIPHERAL BLOOD INVOLVEMENT |
| PP-55 | OSMAN | ŞAHİN | LYMPHOMATOID PAPULOSIS AFTER AUTOLOGOUS STEM CEL TRANSPLANTATION IN A PATIENT WITH DIFFUSE LARGE B CELL LYMPHOMA |
| PP-56 | AYSUN | GÖNDEREN | A RARE CASE REPORT OF PRIMARY BONE LYMPHOMA |
| PP-57 | DENİZ | TUĞCU | HOW CAN WE TREAT HODGKIN LYMPHOMA DEVELOPED AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION DUE TO IL10R DEFICIENCY, CROHN DISEASE AND EBV INFECTİON? |
| PP-58 | BİRGÜL | ÖNEÇ | ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA ASSOCIATED RAYNAUD PHENOMENON AND DIGITAL NECROSIS |
| PP-59 | BİRGÜL | ÖNEÇ | HODGKIN LYMPHOMA PRESENTED WITH MASSIVE PLEURAL EFFUSION |
| PP-60 | EMİN | ABDULLAYEV | CASE REPORT: CARDIAC AMYLOIDOSIS. |
| PP-61 | ATAKAN | TURGUTKAYA | INCREASE OF CD33 EXPRESSION IN MULTIPLE MYELOMA ESTIMATES SHORT SURVIVAL |
| PP-62 | ÜMİT YAVUZ | MALKAN | LENALIDOMIDE PROVIDE BETTER PROGRESSION FREE SURVIVAL THAN THALIDOMIDE AND BORTEZOMIB IN THE FIRST RELAPSE OF MULTIPLE MYELOMA PATIENTS AFTER AUTOLOGOUS TRANSPLANTATION |
| PP-63 | YUSUF | ULUSOY | CLINICAL FEATURES AND OUTCOMES OF SOLITARY PLASMACYTOMAS: SINGLE-CENTER EXPERIENCE FROM TURKEY |
| PP-64 | ESRA | KILIÇ | INVESTIGATION OF B-LYMPHOCYTE F-ACTIN CELL SKELETON IN MULTIPLE MYELOMA PATIENTS |
| PP-65 | ALİ ZAHİT | BOLAMAN | THE ENGRAFTMENT DETERMINANTS AT AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH MYELOMA |
| PP-66 | HALE | BÜLBÜL | SUCCESFUL TREATMENT OF PATIENTS WITH AML AND MDS BY DECITABINE; SINGLE CENTRE EXPERIENCE |
| PP-67 | ŞERİFE | SOLMAZ | GRANULOCYTIC SARCOMA WITH UNUSUAL LOCALIZATIONS (BREAST AND STOMACH) WITHOUT BONE MARROW INVOLVEMENT AFTER ALLOGENEIC TRANSPLANTATION |